NO20073333L - Nye farmasoytiske sammensetninger for vaksiner - Google Patents

Nye farmasoytiske sammensetninger for vaksiner

Info

Publication number
NO20073333L
NO20073333L NO20073333A NO20073333A NO20073333L NO 20073333 L NO20073333 L NO 20073333L NO 20073333 A NO20073333 A NO 20073333A NO 20073333 A NO20073333 A NO 20073333A NO 20073333 L NO20073333 L NO 20073333L
Authority
NO
Norway
Prior art keywords
vaccines
pharmaceutical compositions
new pharmaceutical
vaccine
relates
Prior art date
Application number
NO20073333A
Other languages
English (en)
Norwegian (no)
Inventor
Marinette Moreau
Nicolas Osty
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of NO20073333L publication Critical patent/NO20073333L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20073333A 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner NO20073333L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452838A FR2878746B1 (fr) 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
PCT/FR2005/002995 WO2006059009A1 (fr) 2004-12-02 2005-12-01 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Publications (1)

Publication Number Publication Date
NO20073333L true NO20073333L (no) 2007-08-17

Family

ID=34952132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073333A NO20073333L (no) 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner

Country Status (17)

Country Link
US (1) US8158133B2 (de)
EP (1) EP1817053A1 (de)
JP (1) JP4987725B2 (de)
KR (1) KR20070106988A (de)
CN (1) CN101111262A (de)
AU (1) AU2005311188B2 (de)
BR (1) BRPI0517124A (de)
CA (1) CA2589841A1 (de)
EA (1) EA200701201A1 (de)
FR (1) FR2878746B1 (de)
IL (1) IL183518A (de)
MX (1) MX2007006521A (de)
NO (1) NO20073333L (de)
NZ (1) NZ555743A (de)
UA (1) UA91203C2 (de)
WO (1) WO2006059009A1 (de)
ZA (1) ZA200705079B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2851066A1 (de) * 2013-09-23 2015-03-25 LTS LOHMANN Therapie-Systeme AG Fixierung von Impfstoffformulierungen auf Einrichtungen zur epidermalen Immunisierung durch ölige Adjuvantien

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US478056A (en) * 1892-06-28 Trustees
ZA872532B (en) 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
ES2030494T3 (es) 1987-06-23 1992-11-01 Eniricerche S.P.A. Composicion de una fase conteniendo un aceite perfluorado y uno o varios agentes superficiactivos, util como excipiente para formulaciones cosmeticas y dermatologicas, asi como para aplicaciones biomedicinales.
HUT54610A (en) 1989-05-16 1991-03-28 Puetter Medice Chem Pharm Process for producing optically active 2-aryl-alkanoil acids, first of all 2-aryl-propionic acids
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
JP4104186B2 (ja) * 1995-11-30 2008-06-18 財団法人化学及血清療法研究所 オイルアジュバントワクチンおよびその調製方法
DE69636889T2 (de) * 1995-11-30 2007-12-06 Nof Corp. Öladjuvierter Impfstoff und Verfahren zu seiner Herstellung
WO1998047486A1 (fr) * 1997-04-18 1998-10-29 Taisho Pharmaceutical Co., Ltd. Microemulsion
AU745880B2 (en) * 1998-05-21 2002-04-11 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US6919442B1 (en) * 1998-05-22 2005-07-19 The United States Of America As Represented By The Department Of Health And Human Services Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses
EP1083886B1 (de) 1998-05-27 2003-04-02 Euroceltique S.A. Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
JP4642950B2 (ja) 1999-03-04 2011-03-02 株式会社資生堂 メーキャップ除去用化粧料
JP4570705B2 (ja) 1999-03-04 2010-10-27 株式会社資生堂 メーキャップ除去用化粧料
EP1104767A1 (de) 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- und Disaccharidederivate die sowohl Fettsäureestern als Sulfatestern enthalten
SG137691A1 (en) 2000-09-28 2007-12-28 Chiron Corp Microparticles for delivery of the heterologous nucleic acids
CA2438692C (en) * 2001-02-28 2010-04-27 Akzo Nobel Nv Injectable water-in-oil emulsions
CZ20033515A3 (cs) 2001-06-29 2005-01-12 Chiron Corporation Kompozice vakcíny HCV E1E2
US20030119774A1 (en) * 2001-09-25 2003-06-26 Marianna Foldvari Compositions and methods for stimulating an immune response
DK1613346T3 (da) * 2003-04-04 2013-01-07 Pah Usa 15 Llc Mikrofluidiske olie-i-vand-emulsioner og vaccinesammensætninger
US20060292186A1 (en) * 2003-08-29 2006-12-28 Novagali Pharma Sa Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs

Also Published As

Publication number Publication date
UA91203C2 (ru) 2010-07-12
CA2589841A1 (fr) 2006-06-08
KR20070106988A (ko) 2007-11-06
US20080026006A1 (en) 2008-01-31
EA200701201A1 (ru) 2007-10-26
IL183518A (en) 2011-09-27
MX2007006521A (es) 2007-11-08
US8158133B2 (en) 2012-04-17
BRPI0517124A (pt) 2008-09-30
ZA200705079B (en) 2008-08-27
JP2008521865A (ja) 2008-06-26
EP1817053A1 (de) 2007-08-15
FR2878746B1 (fr) 2007-02-23
FR2878746A1 (fr) 2006-06-09
AU2005311188B2 (en) 2011-07-07
JP4987725B2 (ja) 2012-07-25
WO2006059009A1 (fr) 2006-06-08
AU2005311188A1 (en) 2006-06-08
IL183518A0 (en) 2007-09-20
NZ555743A (en) 2009-06-26
CN101111262A (zh) 2008-01-23

Similar Documents

Publication Publication Date Title
WO2017070620A3 (en) Broad spectrum influenza virus vaccine
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
MX2010008799A (es) Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
WO2007024941A3 (en) Polyvalent vaccine
NO20091395L (no) Nye tiofenderivater
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
TW200642700A (en) Chemically defined stabiliser
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
CY1115838T1 (el) Μεθοδος για τη σταθεροποιηση φαρμακοτεχνικων μορφων που περιεχουν μικροοργανισμους
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
NO20084850L (no) MGLUR5 modulatorer I
CY1111367T1 (el) Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
MX349119B (es) Vacuna de virus de dengue inactivado.
WO2006063053A3 (en) Methods of producing influenza vaccine compositions
WO2007136689A3 (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
DK1810676T3 (da) Levetiracetam formuleringer og fremgangsmåder til deres fremstilling
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
CY1117288T1 (el) Παραγωγα 2-οξο-1-πυρρολιδινυλ ιμιδαζοθειαδιαζολης
EA201070689A1 (ru) Композиция для личного ухода
MY151211A (en) 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
NO20091990L (no) Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
BRPI0909737A2 (pt) compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application